Prof. Angelo Aquino is an associate professor of pharmacology at the Department of Systems Medicine, University of Rome Tor Vergata. He obtained his M.D. degree in medicine (110/110 cum laude) from the University of Rome "La Sapienza" in 1984. In the same year, he earned the qualification of a medical doctor at the University of Pisa. Then, he completed a specialist degree in oncology (70/70 cum laude) at the University of Rome "Tor Vergata" in 1987. Subsequently, he served as Fogarty Visiting Fellow at the Laboratory of Biological Chemistry National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA (1987-90); a research associate at the Department of Experimental Medicine and Biochemical Science (1991–1995); an assistant professor at the Department of Neuroscience (1995–2004); and an associate professor of pharmacology at the Department of Systems Medicine (2004–today). His main interests are 1) studies on the role of protein kinase C and protein phosphorylation in the mechanisms of multidrug resistance and 2) immunopharmacology and the role of pharmacological modulation of tumor antigens in the diagnosis and therapy of tumors..
Prof. Angelo Aquino is an associate professor of pharmacology at the Department of Systems Medicine, University of Rome Tor Vergata. He obtained his M.D. degree in medicine (110/110 cum laude) from the University of Rome "La Sapienza" in 1984. In the same year, he earned the qualification of a medical doctor at the University of Pisa. Then, he completed a specialist degree in oncology (70/70 cum laude) at the University of Rome "Tor Vergata" in 1987. Subsequently, he served as Fogarty Visiting Fellow at the Laboratory of Biological Chemistry National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA (1987-90); a research associate at the Department of Experimental Medicine and Biochemical Science (1991–1995); an assistant professor at the Department of Neuroscience (1995–2004); and an associate professor of pharmacology at the Department of Systems Medicine (2004–today). His main interests are 1) studies on the role of protein kinase C and protein phosphorylation in the mechanisms of multidrug resistance and 2) immunopharmacology and the role of pharmacological modulation of tumor antigens in the diagnosis and therapy of tumors..